Ceapro Inc. Expands Collaborative Research Program with McMaster University to Develop an Inhalable Immuno-Therapeutic/-Prophylactic for COVID-19-Induced Lung Fibrosis
– Continuation of research with McMaster University to validate the anti-fibrotic properties of the Company’s…